Business Bioventus to buy CartiHeal despite financing problems Nick J Adam Jun 21, 2022 US orthologics company Bioventus will acquire Israeli cartilage treatment company CartiHeal, despite… Read More...
Business Elron warns $500m Cartiheal acquisition by Bioventus in jeopardy Nick J Adam May 14, 2022 Elron Ventures (TASE: ELRN) has notified the Tel aviv Stock Exchange that the $500 million sale of… Read More...
Business $500m CartiHeal sale to go ahead after FDA approval granted Nick J Adam Mar 31, 2022 US orthologics company Bioventus (Nasdaq: BVS) can now proceed with its $500 million acquisition of… Read More...